Nine Class I anti-arrhythmic drugs were subdivided into three distinct subclasses (fast, intermediate, and slow) based on the speed of onset of rate-dependent depression of Vmax and APD.
The kinetics of onset of rate-dependent depression of maximum rate of depolarisation (Vmax) of guinea-pig ventricular action potentials were studied for nine Class I anti-arrhythmic drugs using standard microelectrode techniques. The drugs were found to fall into three well-demarcated subgroups with "fast" (lignocaine, tocainide and mexiletine), "intermediate" (quinidine, disopyramide and procainamide) and "slow" (flecainide, encainide and lorcainide) kinetics. The "fast" drugs were found to share the ability to markedly prolong the effective refractory period (ERP) relative to the action potential duration (APD). The "slow" drugs had only minor effects on this parameter. The "intermediate" drugs produced small to moderate increases in ERP relative to APD but in addition significantly prolonged APD, which was shortened by the "fast" drugs. Thus, using the parameters of speed of onset of rate-dependent depression of Vmax and APD it was possible to subdivide the nine Class I drugs into three distinct subclasses.
Terence J. Campbell (Wed,) conducted a other in Class I antiarrhythmic drug effects on guinea-pig ventricle. Nine Class I anti-arrhythmic drugs (lignocaine, tocainide, mexiletine, quinidine, disopyramide, procainamide, flecainide, encainide, lorcainide) vs. Compared to each other was evaluated on Kinetics of onset of rate-dependent depression of maximum rate of depolarisation (Vmax) and effects on effective refractory period (ERP) relative to action potential duration (APD). Nine Class I anti-arrhythmic drugs were subdivided into three distinct subclasses (fast, intermediate, and slow) based on the speed of onset of rate-dependent depression of Vmax and APD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: